PTGX Stock Analysis: Buy, Sell, or Hold?
PTGX - Protagonist Therapeutics, Inc
$129.89
-1.53 (-1.16%)
▼
5d:
-1.22%
30d:
+22.8%
90d:
+31.44%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When PTGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PTGX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: PTGX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: PTGX is currently trading at $129.89, which is considered extended relative to its 30-day fair value range of $101.64 to $128.88. From a valuation perspective, the stock is trading at a discount (Forward PE: -207.7) compared to its historical average (83.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PTGX is in a uptrend. Immediate support is located at $118.27, while resistance sits at $141.10.
Market Sentiment: PTGX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PTGX is in a uptrend. Immediate support is located at $118.27, while resistance sits at $141.10.
Market Sentiment: PTGX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$101.64 -
$128.88
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
Holding PTGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($120.54)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$101.64 -
$128.88
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$118.27
Resistance Level
$141.10
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-207.68
Wall Street Target
$120.54
(-8.3%)
Revenue Growth (YoY)
99.0%
Earnings Growth (YoY)
351.3%
Profit Margin
-154.9%
PE vs Historical
-207.7 vs 83.6
CHEAP
Share & Embed Analysis
Last updated: July 13, 2026 4:22 PM ET
Data refreshes hourly during market hours. Next update: 5:22 PM
Data refreshes hourly during market hours. Next update: 5:22 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Asif Ali
SELL
1750 shares
2026-04-20
Arturo Md Molina
SELL
15000 shares
2026-03-26
Asif Ali
SELL
24765 shares
2026-03-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 61 BUY |
Advanced PTGX Option Strategies
Professional options setups generated by AI based on today's PTGX price and gamma walls.
